These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9246039)

  • 1. Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion.
    Fernández-Rodriguez CM; Prieto J; Quiroga J; Zozaya JM; Andrade A; Rodriguez-Ortigosa C
    Dig Dis Sci; 1997 Jul; 42(7):1416-20. PubMed ID: 9246039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
    Jespersen B; Jensen L; Sørensen SS; Pedersen EB
    Eur J Clin Invest; 1990 Dec; 20(6):632-41. PubMed ID: 1964125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
    Zavala L; Barbella Y; Israel A
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of cyclic 3', 5'-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics.
    Kirstetter P; Moreau R; Vachiery F; Gadano A; Soupison T; Pilette C; Pussard E; Cailmail S; Takahashi H; Lebrec D
    J Gastroenterol Hepatol; 1997 Mar; 12(3):233-6. PubMed ID: 9142641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion.
    Fernández-Rodriguez CM; Prieto J; Quiroga J; Zozoya JM; Andrade A; Núñez M; Sangro B; Penas J
    Hepatology; 1995 Jan; 21(1):35-40. PubMed ID: 7528711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans.
    Kanno K; Hirata Y; Emori T; Ohta K; Eguchi S; Imai T; Marumo F
    Clin Exp Pharmacol Physiol; 1992 Sep; 19(9):619-25. PubMed ID: 1327594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
    Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
    J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exaggerated natriuresis induced by sodium chloride infusion in essential hypertension is accompanied by an exaggerated urinary 3' 5' guanosine monophosphate excretion.
    Widecka K; Celibała R; Goździk J; Syrenicz A; Ciechanowski K; Czekalski S
    Nephrol Dial Transplant; 1993; 8(8):711-5. PubMed ID: 8414156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma cardiac natriuretic peptides associated with enhanced cyclic guanosine monophosphate production in preascitic cirrhosis.
    Iwao T; Oho K; Nakano R; Sakai T; Sato M; Miyamoto Y; Kumamoto M; Sakai K; Sata M; Toyonaga A
    J Hepatol; 2000 Mar; 32(3):426-33. PubMed ID: 10735612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide and urinary cyclic guanosine monophosphate in patients with chronic heart failure.
    Abraham WT; Hensen J; Kim JK; Dürr J; Lesnefsky EJ; Groves BM; Schrier RW
    J Am Soc Nephrol; 1992 Jun; 2(12):1697-703. PubMed ID: 1323337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
    Tesar V; Spicák J; Horký K; Zabka J; Widimský J; Jedlicka J; Marecek Z
    Cas Lek Cesk; 1994 Feb; 133(4):111-5. PubMed ID: 8137382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANF-mediated renal cGMP generation in congestive heart failure.
    Margulies KB; Heublein DM; Perrella MA; Burnett JC
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F562-8. PubMed ID: 1849364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects.
    Skorecki KL; Leung WM; Campbell P; Warner LC; Wong PY; Bull S; Logan AG; Blendis LM
    Am J Med; 1988 Sep; 85(3):375-82. PubMed ID: 2843047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary guanosine 3':5'-cyclic monophosphate but not tissue kallikrein follows the plasma atrial natriuretic factor response to acute volume expansion with saline.
    Lewis HM; Wilkins MR; Selwyn BM; Yelland UJ; Griffith ME; Bhoola KD
    Clin Sci (Lond); 1988 Nov; 75(5):489-94. PubMed ID: 2855478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure.
    Abassi Z; Burnett JC; Grushka E; Hoffman A; Haramati A; Winaver J
    Am J Physiol; 1991 Oct; 261(4 Pt 2):R858-64. PubMed ID: 1656791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
    Gentile S; Bologna E; Terracina D; Angelico M
    Life Sci; 1994; 54(21):1585-93. PubMed ID: 8196477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
    Dussaule JC; Grangé JD; Wolf JP; Lecomte JM; Gros C; Schwartz JC; Bodin F; Ardaillou R
    J Clin Endocrinol Metab; 1991 Mar; 72(3):653-9. PubMed ID: 1847706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activity of cGMP-specific phosphodiesterase (PDE5) contributes to resistance to atrial natriuretic peptide natriuresis in the pregnant rat.
    Ni XP; Safai M; Rishi R; Baylis C; Humphreys MH
    J Am Soc Nephrol; 2004 May; 15(5):1254-60. PubMed ID: 15100365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor.
    Wong KR; Xie MH; Shi LB; Liu FY; Huang CL; Gardner DG; Cogan MG
    Am J Physiol; 1988 Dec; 255(6 Pt 2):F1220-4. PubMed ID: 2849318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.